Valuation : Sirnaomics Ltd.

Market Cap 55.47M 435M 47.79M 45.25M 41.02M 76.95M 5.3B 77.34M 537M 207M 2.7B 208M 204M 8.52B P/E 2024
-0.67x
P/E 2025 -6.46x
Enterprise Value 51.27M 402M 44.17M 41.82M 37.91M 71.12M 4.9B 71.48M 497M 191M 2.49B 193M 188M 7.87B EV / Sales 2024
24.1x
EV / Sales 2025 -
Free-Float
73.19%
Yield 2024 *
-
Yield 2025 -
1 day+3.63%
1 week+1.40%
Current month+5.97%
1 month+0.63%
3 months-10.22%
6 months-40.73%
Current year-47.91%
1 week 3.63
Extreme 3.63
4
1 month 3.63
Extreme 3.63
4.7
Current year 3.63
Extreme 3.63
10.72
1 year 3.63
Extreme 3.63
20.6
3 years 2.35
Extreme 2.35
54.25
5 years 2.35
Extreme 2.35
101
10 years 2.35
Extreme 2.35
101
Manager TitleAgeSince
Chief Executive Officer 48 2024-11-05
Director of Finance/CFO 35 2021-08-31
Compliance Officer 73 2019-12-31
Director TitleAgeSince
Chairman 48 2025-11-30
Director/Board Member 56 2025-02-16
Director/Board Member 50 2025-07-02
Date Insider Type Main position Quantity % Market Cap. Importance
3/30/26 Other 38,000 0.0354%
11/24/24 Other

Chief Executive Officer

12,067 0.0138%
6/5/24 Other

Executive/Senior Manager

5,000 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+3.63%+1.40%-79.19%-91.90% 53.54M
-2.11%-3.44%+41.04%+98.48% 68.24B
-0.23%-4.45%+30.39%+73.64% 62.23B
+1.03%+1.65%-11.95%+384.42% 27.8B
-1.05%-7.30%+25.00%+12.31% 24.86B
+0.84%-6.32%-6.82%-17.59% 24.22B
+0.43%-3.37%+14.85%-19.29% 19.36B
-3.03%-5.19%+192.88%+340.13% 17.28B
-1.94%-6.36%-7.05%+516.16% 14.46B
-1.31%-4.49%+44.25%+156.30% 14.23B
Average -0.39%-3.78%+24.34%+145.27% 27.27B
Weighted average by Cap. -0.83%-3.80%+32.85%+135.87%

Financials

2024 2025
Net sales 1.78M 13.94M 1.53M 1.45M 1.31M 2.47M 170M 2.48M 17.23M 6.62M 86.42M 6.68M 6.53M 273M -
Net income -51.38M -403M -44.27M -41.92M -38M -71.28M -4.91B -71.64M -498M -191M -2.5B -193M -189M -7.89B -14.4M -113M -12.41M -11.75M -10.65M -19.98M -1.38B -20.08M -140M -53.67M -700M -54.09M -52.91M -2.21B
Net Debt -3.71M -29.1M -3.2M -3.03M -2.74M -5.15M -355M -5.17M -35.96M -13.83M -180M -13.94M -13.63M -570M -4.2M -32.97M -3.62M -3.43M -3.11M -5.83M -402M -5.86M -40.73M -15.66M -204M -15.79M -15.44M -646M
Logo Sirnaomics Ltd.
Sirnaomics Ltd. is an investment holding company. The Company and its subsidiaries are clinical-stage biotechnology companies that are engaged in developing and commercializing ribonucleic acid interference (RNAi) technology and multiple therapeutics. The Company is engaged in discovering and developing drugs for indications with unmet medical needs in areas. Its lead clinical drug candidates include STP705 and STP707. Its STP705 is a multi-targeted siRNA therapeutic advancing clinical development across two oncology indications: squamous cell carcinoma in situ (isSCC) and basal cell carcinoma (BCC). Its STP707 is an intravenous siRNA therapeutic being evaluated in phase I clinical trial for multiple solid tumors, including colorectal, pancreatic, liver, and metastatic melanoma cancers. It is capitalizing on its dual delivery platforms, which include Polypeptide nanoparticle (PNP) and GalAhead.
Employees
-
Date Price Change Volume
26-09-11 HK$3.995 +3.63% 41,100
26-09-10 HK$3.855 +1.98% 19,150
26-09-09 HK$3.780 -1.95% 30,950
26-09-08 HK$3.855 -1.03% 12,000
26-09-07 HK$3.895 +2.50% 16,350
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5095USD
Average target price
9.200USD
Spread / Average Target
+1,705.74%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2257 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!